https://www.thebodypro.com/category/hiv-treatment-strategies/tag/croi-conference-on-retroviruses-and-opportunistic-infections
HIV Treatment Strategies

CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

pregnant check-up

Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed

Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.

By Barbara Jungwirth
vaginal ring

Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals

A CROI 2020 roundup of studies on birth control and women living with HIV.

By Barbara Jungwirth
birthday candles

HIV Life Expectancy in U.S. Now Matches General Population—With Some Big “Buts”

The biggest may be that more of an HIV-positive person’s equally long lifespan will be spent managing comorbidities, one large study found.

By Myles Helfand
aging face

This Week in HIV Research: Playing Catchup on the Aging Front

March 12, 2020: The impact of age on viral suppression and immunologic recovery; chronic obstructive pulmonary disease risk among older PLWHIV; sex-based differences in older men vs. women; effect of aging on drug-drug interactions.

By Barbara Jungwirth and Myles Helfand
holding hands

Scientists Report Documented Sustained HIV Remission in a 4-Year-Old Child

Treating newborns with antiretroviral therapy in the hours after birth may help put HIV into remission.

By Sony Salzman
injectable

The Monthly Injectable HIV Drug Works Just as Well When Given Every Two Months

Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.

By Sony Salzman
stem cell transplant device

Durable HIV Remission in London Patient, the Second Person Cured of HIV

Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.

By Sony Salzman
Marrazzo at CROI

CROI 2020: What to Expect in HIV Science From This Year’s Conference

COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.

By Sony Salzman
TAF as Effective as TDF in Cisgender Women, With Fewer Side Effects Img

TAF as Effective as TDF in Cisgender Women, With Fewer Side Effects

A pooled analysis presented at CROI 2019 showed fewer kidney and bone density issues with tenofovir alafenamide in cisgender women than were found with the older formulation.

By Martha Kempner
Viral Reservoir Can Explain Persistent Low Level Viremia With Good Adherence on ART Img

Viral Reservoir Can Explain Persistent Low Level Viremia With Good Adherence on ART

A CROI 2019 study suggests the dynamics of HIV proliferation in the viral reservoir might explain why viral load sometimes fails to become undetectable, especially when adherence is good.

By Simon Collins for HIV i-Base